Article Title: A systematic literature review to assess the burden of herpes zoster disease in China
Authors: Yin D, Van Oorschot D, Jiang N, et al.
Journal: Expert Review of Anti-infective Therapy
DOI: https://doi.org/10.1080/14787210.2020.1792290
The plain language summary was incorrectly set when the article was first published.
It has now been corrected in the original article.
Plain language summary
What is the context?
Although Herpes zoster (shingles) is a common disease of older age, the burden of disease in China is not well described.
32% of the Chinese population is aged 50 years and Older and this proportion is increasing. As a result of the ageing population, the public burden associated with shingles is expected to increase over time.
What is new?
We accessed published studies in the English and Chinese language literature to explore
available information describing shingles in China.
The incidence of shingles in Taiwan, Hong Kong and mainland China appears to be similar to other countries, although reliable population-based data are currently sparse in Hong Kong and mainland China.
What is the impact?
Data describing the disease burden due to shingles are currently heterogeneous throughout China. This review is a first step to determine those populations which could benefit most from shingles vaccination.
Preventing shingles through vaccination could benefit the individual as well as provide potentially significant economic benefits for the individual, the employer and the economy.